{
    "clinical_study": {
        "@rank": "114364", 
        "acronym": "DTSC", 
        "arm_group": {
            "arm_group_label": "Anodyne", 
            "arm_group_type": "Experimental", 
            "description": "To evaluate the efficacy treatment of lower extremity pathologies from neurological ischemia disorders using the  Monochromatic Infrared Photo Energy (MIRE)"
        }, 
        "brief_summary": {
            "textblock": "To evaluate the efficacy treatment of lower extremity pathologies derived from neurological\n      ischemia disorders using the combination of Monochromatic Infrared Photo Energy (MIRE) and\n      Transcutaneous Electrical Nerve Stimulation (TENS) therapies."
        }, 
        "brief_title": "Study Neurological Ischemia Lower Extremity Pain and Swelling", 
        "completion_date": {
            "#text": "March 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Lower Extremity Swelling Acute", 
        "condition_browse": {
            "mesh_term": [
                "Edema", 
                "Ischemia"
            ]
        }, 
        "detailed_description": {
            "textblock": "Although there are a number of pain disorders, associated with back, or lower extremity pain\n      and swelling, the American Association of Sensory Electrodiagnostic Medicine (AASEM/ DTSC)\n      study programs will accumulate received data following a protocol of treatment performed for\n      the purpose of eliminating pain, reducing swelling, and accelerating recovery periods as\n      well as to record the success or failure and/or improvement of the malfunctioning body part.\n\n        -  Condition: Neuropathic Pain, Tingling or Numbness derived from neurological Ischemia\n\n        -  Intervention: Treatments of Monochromatic Infrared Photo Energy (MIRE) in combination\n           with Electronic Signal Treatment (TENS) therapy\n\n        -  Study Type: Interventional\n\n        -  Study Design:\n\n             1. Allocation: Non-Randomized\n\n             2. Endpoint Classification: Efficacy Study\n\n             3. Intervention Model: Single Group Assignment\n\n             4. Masking: Open Label\n\n             5. Primary Purpose: Scientific record of treatment success or failure"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  In the investigator's judgment, a high probability of 5 year survival and compliance\n             with the study visit schedule.\n\n        Ability to comprehend and sign an informed consent document prior to study enrollment.\n\n        Exclusion Criteria:\n\n          -  Any other excluding factors that, according to the investigator's judgment, would\n             preclude enrollment in the study."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "90 Years", 
            "minimum_age": "25 Years"
        }, 
        "enrollment": {
            "#text": "1000", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 28, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01979367", 
            "org_study_id": "DTSC030113"
        }, 
        "intervention": {
            "arm_group_label": "Anodyne", 
            "description": "Subjects will be treated with MIRE therapy using the Anodyne\u00ae device within 72 hours of previous treatments, and in accordance with the Anodyne\u00ae package insert indications for use 30 to 45 minutes professional units on power setting of 8,. In addition, patients will undergo TENS therapy with the use of either the Avazzia\u00ae Pro Sport or TENS 3000 (for no less than 30 mins, both on label) in accordance with the indications for use of each TENS device, for a minimum of 15 minutes at the subjective site for pain and each vertebrae nerve base, when impairment is confirmed with the objective Small Pain Fiber (SPF) Nerve Conduction Study (NCS) test performed.", 
            "intervention_name": "Anodyne", 
            "intervention_type": "Device"
        }, 
        "intervention_browse": {
            "mesh_term": "Analgesics"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 5, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Las Vegas", 
                        "country": "United States", 
                        "state": "Nevada", 
                        "zip": "89117"
                    }, 
                    "name": "Neuropathy & Pain Center of Las Vegas"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hillsboro", 
                        "country": "United States", 
                        "state": "Oregon", 
                        "zip": "97006"
                    }, 
                    "name": "Living PDX"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hillsboro", 
                        "country": "United States", 
                        "state": "Oregon", 
                        "zip": "97123"
                    }, 
                    "name": "Chad Pfefer, M.D."
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Austin", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "78758"
                    }, 
                    "name": "Austin Primary Care Physicians"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cedar Park", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "78613"
                    }, 
                    "name": "Austin Primary Care Physicians"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "To Evaluate the Efficacy Treatment of Lower Extremity Pathologies Derived From Neurological Ischemia Disorders", 
        "overall_official": [
            {
                "affiliation": "American Association of Sensory Electrodiagnostic Medicine", 
                "last_name": "Chad T Pfefer, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "American Association of Sensory Electrodiagnostic Medicine", 
                "last_name": "Nandini Kohli, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "American Association of Sensory Electrodiagnostic Medicine", 
                "last_name": "Robert Odell, M.D. PhD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Enrolling by invitation", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Scientific record of treatment success or failure", 
            "safety_issue": "No", 
            "time_frame": "3 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01979367"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "American Association of Sensory Electrodiagnostic Medicine", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "American Association of Sensory Electrodiagnostic Medicine", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "March 2012", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}